Parathyroid hormone uses multiple mechanisms to arrest the cell cycle progression of osteoblastic cells from G1 to S phase.
about
Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progressionDistinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiationCatabolic and anabolic actions of parathyroid hormone on the skeletonMitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferationEffects of enamel matrix derivative on the proliferation and osteogenic differentiation of human gingival mesenchymal stem cells.Microarray-based analysis of cell-cycle gene expression during spermatogenesis in the mouse.Profile of teriparatide in the management of postmenopausal osteoporosis.Calpain modulates cyclin-dependent kinase inhibitor 1B (p27(Kip1)) in cells of the osteoblast lineage.The effect of bovine parathyroid hormone withdrawal on MC3T3-E1 cell proliferation and phosphorus metabolism.Nmp4/CIZ suppresses the response of bone to anabolic parathyroid hormone by regulating both osteoblasts and osteoclasts.The elements of human cyclin D1 promoter and regulation involved.Molecular and cellular mechanisms of the anabolic effect of intermittent PTHBuilding bone to reverse osteoporosis and repair fracturesOverview of calpain-mediated regulation of bone and fat mass in osteoblasts.Constitutively active PTH/PTHrP receptor specifically expressed in osteoblasts enhances bone formation induced by bone marrow ablation.Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administrationIntermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblastsMitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.PTH and PTHrP signaling in osteoblastsEndogenous FGF-2 is critically important in PTH anabolic effects on bone.The new frontier of bone formation: a breakthrough in postmenopausal osteoporosis?Emerging therapeutic targets for osteoporosis treatment.Mitogen-activated protein kinase phosphatase-1: function and regulation in bone and related tissues.Parathyroid hormone (1-34) modulates odontoblast proliferation and apoptosis via PKA and PKC-dependent pathways.Parathyroid hormone-potentiated connective tissue growth factor expression in human renal proximal tubular cells through activating the MAPK and NF-kappaB signalling pathways.Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts.Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro.Sex dimorphic regulation of osteoprogenitor progesterone in bone stromal cells.Parathyroid hormone induces mitogen-activated kinase phosphatase 1 in murine osteoblasts primarily through cAMP-protein kinase A signaling.MKP-1 knockout does not prevent glucocorticoid-induced bone disease in mice.Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner.Defective PTH regulation of sodium-dependent phosphate transport in NHERF-1-/- renal proximal tubule cells and wild-type cells adapted to low-phosphate media.Sequential culture on biomimetic nanoclay scaffolds forms three-dimensional tumoroids.
P2860
Q21202830-D2D06D7B-4E12-4485-BD02-ABF8863D087DQ24314684-98A3B457-8D14-4415-AB53-41E8CC966E78Q26828873-08847959-E5B9-47FF-86E7-5ADDC4750E25Q33725761-E2D50BAC-2319-48E2-B188-F7C4E9ED31A8Q33827031-ED4D030B-F611-4D5E-91E9-C9EF6D43EFA7Q34210995-317A71D6-82EA-46A9-BDBC-63D6001AAF1AQ34272197-9717543D-0A0D-46B2-A700-1DCC3AECA9EEQ35036886-F57BBA84-0E92-4B94-98FF-87D8C8001ABDQ35182148-9225E7F3-D526-42F9-B2AB-61D008D41FEEQ35432065-81E48F05-18FB-4566-9F64-C6BC8A6D5A5CQ36002446-864D118D-5DE8-4828-B8DB-97E0891A8753Q36016775-7C93FC8E-EEEE-43D6-8917-3094B556F119Q36407024-73D10AB5-F253-4579-A712-E485B2D88666Q36476441-BC073756-E264-45E9-9BF6-E071F0FA2E7DQ36950207-DDFFF4E2-DE22-46A5-8FC7-A899A18518BAQ36976441-6CBBFCEF-91C7-4D8A-9A15-3966D0C7F240Q37127210-278367CF-F35C-45AF-BA63-5C36468C53E0Q37198198-F8ABC609-8744-4386-9A82-E87055178AF8Q37297529-D0E86760-2281-4BC2-BE54-032506159BF2Q37390523-793C2C04-2A66-463E-B678-3BE7C7078064Q37470341-9E7F42D8-ECE0-47ED-9FD0-64A0F8F5C3F1Q38207147-A094442F-18B8-41E3-A76C-3CA125DE438EQ38794453-517BE819-AABF-4F45-8E5F-AB08EF1571D9Q38976534-1807706F-8EBA-4DFA-A45C-D845F681BFA4Q39660878-3B060C84-AEBA-4C98-8AA4-14724C7AE80DQ40095819-88F84538-754F-410B-AE5B-C0DAD3970AA5Q41449124-80B570F3-FF0B-4202-92FB-96FC3230ABD3Q42118543-0335D63F-C9BB-445D-82D8-704E32D5B784Q42777568-996E0028-A652-462A-ABF1-8B5F4D355F76Q46927975-0978EA0A-349F-4E1C-ACA9-B8A9BBFF1E0FQ46957183-AB4AE472-FF85-45BA-B647-68F29F581A45Q50591956-968DABC7-6060-4B73-A59F-EDB7D66AE304Q51441314-3E694723-B900-4625-888B-6DCB8FF1B9FDQ51526062-7E4D80F6-F8C6-4F77-8934-808D2C381272
P2860
Parathyroid hormone uses multiple mechanisms to arrest the cell cycle progression of osteoblastic cells from G1 to S phase.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Parathyroid hormone uses multi ...... stic cells from G1 to S phase.
@en
type
label
Parathyroid hormone uses multi ...... stic cells from G1 to S phase.
@en
prefLabel
Parathyroid hormone uses multi ...... stic cells from G1 to S phase.
@en
P2093
P2860
P356
P1476
Parathyroid hormone uses multi ...... stic cells from G1 to S phase.
@en
P2093
Jae-Kyun Ko
Nicola C Partridge
P2860
P304
P356
10.1074/JBC.M409846200
P407
P577
2004-10-28T00:00:00Z